Global Health Ltd

AI
Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Global Health Ltd

₹ 1,195 -3.06%
22 Oct 3:54 p.m.
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

Hospital Count[1]
Global Health operates 6 hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida. Spanning an area of 5.6 million sq. ft., they have 3,435 installed beds as on Sep 30, 2025. They provide healthcare services in over 30 medical specialties and engage 2,000+ doctors led by highly experienced department heads.

Website BSE NSE
  • Market Cap ₹ 32,125 Cr.
  • Current Price ₹ 1,195
  • High / Low ₹ 1,544 / 955
  • Stock P/E 56.2
  • Book Value ₹ 147
  • Dividend Yield 0.04 %
  • ROCE 17.4 %
  • ROE 15.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 80.7% CAGR over last 5 years

Cons

  • Stock is trading at 8.22 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare BSE 1000 Nifty 500 BSE 150 MidCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
780 844 836 809 861 957 943 931 1,031 1,099 1,121 1,159 1,304
595 631 620 629 675 728 706 707 784 868 904 915 1,017
Operating Profit 184 213 216 179 186 228 238 225 247 231 217 244 287
OPM % 24% 25% 26% 22% 22% 24% 25% 24% 24% 21% 19% 21% 22%
15 21 18 27 22 18 16 -27 20 36 -15 37 22
Interest 18 20 18 18 18 16 16 15 14 17 22 27 27
Depreciation 40 43 44 45 47 49 48 49 45 50 61 67 69
Profit before tax 141 171 172 143 144 181 189 133 208 200 120 187 213
Tax % 28% 27% 28% 11% 26% 28% 24% 24% 24% 21% 21% 24% 26%
102 125 124 127 106 131 143 101 159 158 95 142 157
EPS in Rs 3.80 4.66 4.61 4.74 3.96 4.87 5.32 3.78 5.92 5.89 3.54 5.36 5.90
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
1,382 1,343 1,456 1,500 1,447 2,167 2,710 3,275 3,692 4,410 4,683
1,081 1,218 1,283 1,309 1,250 1,709 2,073 2,466 2,806 3,480 3,705
Operating Profit 301 125 172 192 197 458 637 809 886 930 979
OPM % 22% 9% 12% 13% 14% 21% 24% 25% 24% 21% 21%
45 49 50 44 31 39 49 75 29 98 80
Interest 14 28 38 57 73 86 86 84 74 90 92
Depreciation 70 86 102 115 123 130 150 173 194 223 246
Profit before tax 262 60 83 64 32 281 449 627 647 715 720
Tax % 35% 45% 38% 43% 11% 30% 27% 24% 26% 23%
170 33 51 36 29 196 326 478 481 554 552
EPS in Rs 7.02 1.36 2.09 1.47 1.16 7.75 12.16 17.81 17.92 20.70 20.69
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 2%
Compounded Sales Growth
10 Years: 12%
5 Years: 25%
3 Years: 18%
TTM: 21%
Compounded Profit Growth
10 Years: 13%
5 Years: 81%
3 Years: 19%
TTM: 0%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 18%
1 Year: -12%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 16%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 48 48 49 49 50 51 54 54 54 54
Reserves 976 1,136 1,246 1,300 1,333 1,565 2,375 2,852 3,333 3,908
165 456 787 929 931 1,109 1,122 802 718 1,190
295 343 347 388 380 421 547 572 662 753
Total Liabilities 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905
914 1,094 1,194 1,703 1,616 1,776 2,050 2,236 2,514 3,795
CWIP 12 317 666 382 464 439 327 388 533 132
Investments 0 0 0 0 0 0 0 0 3 3
559 573 570 581 615 930 1,720 1,656 1,716 1,975
Total Assets 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
228 63 166 175 242 311 645 612 624 714
-241 -69 -249 -87 -239 -421 -342 -441 -721 -1,089
-7 9 97 -1 -81 160 346 -514 -97 272
Net Cash Flow -20 3 14 87 -78 50 648 -343 -194 -103
Free Cash Flow 71 -81 -133 -13 100 38 409 335 110 -123
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 108% 93% 135% 121% 131% 89% 118% 98% 89% 90%

Ratios

Consolidated / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 20 41 41 36 34 30 26 24 29 34
Inventory Days 28 26 26 43 42 36 35 32 28 29
Days Payable 92 124 142 147 138 90 114 90 81 89
Cash Conversion Cycle -45 -56 -75 -67 -62 -24 -52 -34 -24 -26
Working Capital Days -23 -33 -18 -31 -48 -20 -37 -32 -21 -7
ROCE % 6% 6% 5% 15% 17% 20% 20% 17%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ALOS (Average Length of Stay)
days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR
Bed Occupancy Rate
%
Census Beds (Operational Capacity)
count
In-Patient Volume (IPD)
count
Out-Patient Volume (OPD)
count
Total Beds (Installed Capacity)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
33.05% 33.04% 33.04% 33.04% 33.03% 33.03% 33.01% 33.01% 33.01% 33.01% 33.00% 33.00%
11.36% 12.10% 12.94% 12.21% 12.48% 11.76% 11.54% 11.41% 10.54% 10.15% 9.46% 9.92%
11.15% 10.25% 10.57% 11.11% 10.51% 11.93% 12.20% 12.97% 13.99% 14.76% 16.89% 17.01%
44.45% 44.60% 43.44% 43.64% 43.98% 43.28% 43.19% 42.56% 42.41% 42.01% 40.55% 39.96%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.06% 0.06% 0.08% 0.09% 0.12%
No. of Shareholders 1,24,7751,66,2531,55,3071,49,7221,48,6331,54,6881,56,3721,55,8061,51,2411,47,3901,40,5311,35,371

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls